Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
Approximately 30-60 minutes (varies by delivery method and formulation)
Delivery
Subcutaneous or intravenous injection in research settings; synthetic analogs and modified forms under development for improved stability
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Humanin is a naturally occurring mitochondrial-derived peptide (MDP) consisting of 24 amino acids that plays a crucial role in cellular protection and metabolic regulation. It is encoded within the mitochondrial genome and acts as a cytoprotective factor against oxidative stress, inflammation, and cellular aging. Humanin has emerged as a promising therapeutic target for metabolic disorders, neurodegenerative diseases, and age-related conditions.
Humanin is primarily studied in research settings with dosing protocols varying based on the condition and delivery method. Typical research protocols involve subcutaneous or intravenous administration with dosages ranging from micrograms to milligrams per kilogram body weight. In animal studies, daily or intermittent dosing regimens have been employed. Clinical research in humans is still in early stages, with optimal dosing and frequency yet to be established.
Humanin exerts its cytoprotective effects by binding to multiple cellular receptors, including the CNTFR/WSX-1/gp130 trimeric receptor complex and FPRL1/2. It activates survival signaling pathways such as PI3K/AKT and STAT3, while inhibiting pro-apoptotic proteins like BAX and Bid. Humanin reduces oxidative stress by enhancing mitochondrial function, decreasing reactive oxygen species production, and suppressing inflammatory cascades including NF-κB activation. It also modulates cellular metabolism and insulin sensitivity.
Humanin is a naturally occurring mitochondrial-derived peptide (MDP) consisting of 24 amino acids that plays a crucial role in cellular protection and metabolic regulation. It is encoded within the mitochondrial genome and acts as a cytoprotective factor against oxidative stress, inflammation, and cellular aging. Humanin has emerged as a promising therapeutic target for metabolic disorders, neurodegenerative diseases, and age-related conditions.
Humanin has an approximate half-life of Approximately 30-60 minutes (varies by delivery method and formulation). The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.
Humanin is typically delivered via subcutaneous or intravenous injection in research settings; synthetic analogs and modified forms under development for improved stability. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.
Humanin exerts its cytoprotective effects by binding to multiple cellular receptors, including the CNTFR/WSX-1/gp130 trimeric receptor complex and FPRL1/2. It activates survival signaling pathways such as PI3K/AKT and STAT3, while inhibiting pro-apoptotic proteins like BAX and Bid. Humanin reduces oxidative stress by enhancing mitochondrial function, decreasing reactive oxygen species production, and suppressing inflammatory cascades including NF-κB activation. It also modulates cellular metabolism and insulin sensitivity.
Studied benefits of Humanin include: Protects against oxidative stress and mitochondrial dysfunction, Improves metabolic health and insulin sensitivity in liver and other tissues, Supports bone health and reduces glucocorticoid-induced bone loss, Enhances cellular survival under hypoxic and ischemic conditions, Reduces age-related cellular inflammation (inflammaging), May improve semen quality and reproductive function, Shows potential as a biomarker for neurodegenerative diseases including Alzheimer's, Demonstrates anti-apoptotic properties in various cell types. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.
Reported side effects of Humanin include: Limited human safety data available as research is in early stages, Potential immune system modulation effects require further study, Long-term effects of exogenous administration unknown, Possible interactions with metabolic signaling pathways, Safety profile in various disease states not fully characterized. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.
Other recovery compounds in the Peptides Calculator library.
Half-life · Approximately 1-2 hours (estimated based on similar short peptides)
Half-life · Not extensively characterized; short peptides typically have half-lives of minutes to hours
Half-life · Estimated 1-3 hours (typical for short tripeptides)
Half-life · 30-60 minutes
Half-life · Approximately 2-3 hours
Half-life · Unknown - insufficient pharmacokinetic data